title: Targeted therapy in gynecologic cancers: Ready for prime time?
authors.affiliation: Department of Obstetrics and Gynecology, Gynecologic Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
authors.forename: Muhieddine
authors.initials: M
authors.lastname: Seoud
authors.affiliation: Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
authors.forename: Elisabeth Åvall
authors.initials: EÅ
authors.lastname: Lundqvist
authors.affiliation: Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
authors.forename: Keiichi
authors.initials: K
authors.lastname: Fujiwara
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D015195:Drug Design; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D058990:Molecular Targeted Therapy; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents